Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles

MLA

Evers, Martijn J. W., et al. “Delivery of Modified MRNA to Damaged Myocardium by Systemic Administration of Lipid Nanoparticles.” Journal of Controlled Release, vol. 343, pp. 207–16. EBSCOhost, https://doi.org/10.1016/j.jconrel.2022.01.027. Accessed 2 Nov. 2024.

APA

Evers, M. J. W., Du, W., Yang, Q., Kooijmans, S. A. A., Vink, A., van Steenbergen, M., Vader, P., de Jager, S. C. A., Fuchs, S. A., Mastrobattista, E., Sluijter, J. P. G., Lei, Z., Schiffelers, R., Afd Pharmaceutics, Virologie, & Pharmaceutics. (n.d.). Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles. Journal of Controlled Release, 343, 207–216. https://doi.org/10.1016/j.jconrel.2022.01.027

Chicago

Evers, Martijn J.W., Wenjuan Du, Qiangbing Yang, Sander A.A. Kooijmans, Aryan Vink, Mies van Steenbergen, Pieter Vader, et al. 2024. “Delivery of Modified MRNA to Damaged Myocardium by Systemic Administration of Lipid Nanoparticles.” Journal of Controlled Release 343: 207–16. Accessed November 2. doi:10.1016/j.jconrel.2022.01.027.